Health
FDA Authorizes Marketing of Device to Improve Gait in Multiple Sclerosis Patients – WebWire
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate…
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS). The device is intended to be used by prescription only as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and older. The device, called Portable Neuromodulation Stimulator (PoNS), is a neuromuscular tongue stimulator that consists of a non-implantable apparatus…
-
Noosa News22 hours agoBlute’s Bar Is Picking Up Where The Bearded Lady Left Off, Adding Live Music to Its Late-Night Karaoke Sing-Alongs
-
Noosa News23 hours agoBrawl at busy intersection at Ashmore on the Gold Coast ends in heavy fines
-
General20 hours agoDarwin hosts its first Asian Cup qualifier match, deepening cultural ties between nations
-
Noosa News22 hours agoToolbox murder was a punishment gone wrong, court told